Leila Akkari and Tineke Lenstra to join Oncode Institute

26-11-2018

Leila Akkari and Tineke Lenstra have been selected to join Oncode Institute as junior investigators. Together with five other talented female scientists, they were selected out of 56 applicants, based on their track record, research focus and potential to contribute to the mission of Oncode.

Through the Oncode Female Junior Investigator programme, Oncode has dedicated funds within its budget to support young female scientists.

Leila Akkari (division Division Tumor Biology & Immunology) investigateshow microenvironment components such as tumor-associated macrophages and their molecular mediates fuel cancer progression and impact on cancer recurrence after treatment. The Selection Committee highly valued the translational outlook of Dr. Leila Akkari's research, which bridges fundamental research with the clinic.

Tineke Lenstra (Division gene regulation) uses state of the art single-cell imaging approaches to understand the mechanisms of gene expression regulation in tumor cells. By studying transcription dynamics in single cells, she and her group aim to understand how the molecular mechanisms of transcription regulation affect cell fate decisions and contributes to cancer progression.

Leila Akkari and Tineke Lenstra to join Oncode Institute

This site uses cookies